Tag Archives: Krystexxa

FTC to Allow Tepezza Manufacturer to be Bought By Amgen Amid Growing Hearing Loss Litigation

September 12, 2023 By: Irvin Jackson

The deal seeks to prevent Amgen from leveraging its near-monopoly on Tepezza and other Horizon drugs into an overwhelming competitive advantage.
FTC Files Lawsuit To Prevent Amgen From Acquiring Manufacturer of Tepezza, Krystexxa

May 19, 2023 By: Irvin Jackson

Acquiring Tepezza and Krystexxa would give Amgen a monopoly on those treatments, which it could then use to smother competition, the FTC warns

Change Healthcare Data Breach Settlement Talks To Be Explored Early in MDL (Posted 2 days ago)

Court has ordered parties to meet separately with a U.S. Magistrate Judge over the next two months, to discuss the best timing and structure for settlement negotiations to resolve Change Healthcare data breach lawsuits.

Motion Filed To Centralize Depo-Provera Lawsuits in Federal MDL Over Brain Tumor Risks (Posted 3 days ago)

A group of plaintiffs have petitioned the U.S. Judicial Panel on Multidistrict Litigation to consolidate all Depo-Provera lawsuits before one federal judge for coordinated pretrial proceedings.

Tepezza Hearing Damage Emerged After 5 Months of IV Infusions for Thyroid Eye Disease: Lawsuit (Posted 3 days ago)

Lawsuit alleges a man suffered permanent hearing loss after several months of IV infusions of Tepezza, indicating that the drug maker delayed adding warnings to the thyroid eye disease drug label.

Tag Archives: Krystexxa

FTC to Allow Tepezza Manufacturer to be Bought By Amgen Amid Growing Hearing Loss Litigation

FTC Files Lawsuit To Prevent Amgen From Acquiring Manufacturer of Tepezza, Krystexxa

More Top Stories

Review A Case